Royal Bank Of Canada Abb Vie Inc. Put Options Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $47,946 - $54,630	-300 Reduced 1.48%	20,000 $3.64 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $2.65 Million - $3.3 Million	20,000 Added 6666.67%	20,300 $2.74 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $5.35 Million - $6.16 Million	-37,000 Reduced 99.2%	300 $47,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $2.77 Million - $3.32 Million	20,000 Added 115.61%	37,300 $6.03 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $40,263 - $46,179	300 Added 1.76%	17,300 $2.32 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $21.7 Million - $27 Million	-164,600 Reduced 90.64%	17,000 $2.76 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $12.6 Million - $14.3 Million	-118,800 Reduced 39.55%	181,600 $19.6 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $31.6 Million - $35.2 Million	300,400 New	300,400 $33.8 Million

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $321B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.